Mary Susan Brady

8PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 19, 2022
Neoadjuvant therapy for melanoma: A critical appraisal.

Sophia K McKinley, Mary S Brady

|Jan 29, 2021
Therapeutic Implications of Detecting MAPK-Activating Alterations in Cutaneous and Unknown Primary Melanomas.

Alexander N Shoushtari, Walid K Chatila, Arshi Arora

|Oct 01, 2020
Neoadjuvant immunotherapy for melanoma.

Ann Y Lee, Mary S Brady

|Dec 22, 2018
Clinical implications of the eighth edition of the American Joint Committee on Cancer melanoma staging.

Joseph G Crompton, Elizabeth Gilbert, Mary S Brady

|Dec 02, 2017
Transected thin melanoma: Implications for sentinel lymph node staging.

Garth Herbert, Giorgos C Karakousis, Edmund K Bartlett

Pageof 2